Minze Health and Medtronic Collaborate on Digital Therapy for Overactive Bladder in EMEA
ANTWERP, Belgium – November 12, 2025 — Minze Health, a digital health company focused on urinary and bladder conditions,...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
ANTWERP, Belgium – November 12, 2025 — Minze Health, a digital health company focused on urinary and bladder conditions,...
Dateline — SALT LAKE CITY, November 11, 2025:Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostic testing...
Dateline Introduction – Horsham, Pennsylvania, November 10, 2025:OrtoWay-US Inc., a German-American MedTech innovator specializing in spinal surgery instrumentation, announced...
Fremont, Calif. – November 6, 2025 Cytek Biosciences, Inc. (Nasdaq: CTKB), a leader in high-resolution cell analysis instrumentation, announced...
COPENHAGEN, November 6, 2025 — GN Store Nord A/S (GN) reported a strong Q3 2025 performance, achieving 1% organic...
BOERNE, Texas, Oct. 8, 2025 – Prytime Medical Devices, Inc., a leader in endovascular hemorrhage control and resuscitation, announced...
SAN FRANCISCO, Calif., Oct. 7, 2025 — Verana Health announced the expansion of its MIPS Advisory Services, offering enhanced...
TORINO, Italy – October 2, 2025 – AorticLab has achieved a major milestone with the U.S. Food and Drug...
CINCINNATI, OHIO, September 16, 2025 – Meridian Bioscience, Inc., a global leader in diagnostics and life science raw materials,...
AliveDx, a global in-vitro diagnostics innovator, today announced it has submitted a 510(k) premarket notification to the U.S. Food...
